Articles with "lassa fever" as a keyword



Photo from academic.microsoft.com

Assessment of antiviral therapeutics in animal models of Lassa fever.

Sign Up to like & get
recommendations!
Published in 2019 at "Current opinion in virology"

DOI: 10.1016/j.coviro.2019.06.010

Abstract: Lassa virus (LASV) is an emerging zoonotic virus endemic in West Africa that can cause severe haemorrhagic Lassa fever (LF) in humans. LF recently gained international attention as a prominent infectious disease, leading to increasingly… read more here.

Keywords: west africa; therapeutics animal; assessment antiviral; antiviral therapeutics ... See more keywords
Photo by randominstitute from unsplash

A challenging response to a Lassa fever outbreak in a non endemic area of Sierra Leone in 2019 with export of cases to The Netherlands

Sign Up to like & get
recommendations!
Published in 2022 at "International Journal of Infectious Diseases"

DOI: 10.1016/j.ijid.2022.02.020

Abstract: Introduction On November 20, 2019, the Sierra Leone International Health Regulations (IHR) National Focal Point was notified of an exported case of Lassa fever in The Netherlands, by a Dutch doctor who previously practiced in… read more here.

Keywords: sierra leone; case; response; lassa fever ... See more keywords
Photo from wikipedia

Vaccine platforms for the prevention of Lassa fever

Sign Up to like & get
recommendations!
Published in 2019 at "Immunology Letters"

DOI: 10.1016/j.imlet.2019.03.008

Abstract: Abstract Lassa fever is an acute viral haemorrhagic illness caused by Lassa virus (LASV), which is endemic throughout much of West Africa. The virus primarily circulates in the Mastomys natalensis reservoir and is transmitted to… read more here.

Keywords: fever vaccine; platforms prevention; fever; vaccine platforms ... See more keywords
Photo from wikipedia

Meeting report: WHO consultation on accelerating Lassa fever vaccine development in endemic countries, Dakar, 10-11 September 2019.

Sign Up to like & get
recommendations!
Published in 2020 at "Vaccine"

DOI: 10.1016/j.vaccine.2020.01.017

Abstract: At the time of writing in 2019, there have been 754 confirmed cases of Lassa fever in Nigeria, 21% of whom have died. Lassa is on the priority pathogen list for WHO's R&D Blueprint for… read more here.

Keywords: fever; september 2019; vaccine development; lassa fever ... See more keywords
Photo from wikipedia

PREVALENCE AND OUTCOME OF LASSA FEVER AMONG HOSPITALIZED PATIENTS IN EBONYI STATE, NIGERIA, 2018 - 2019.

Sign Up to like & get
recommendations!
Published in 2020 at "Virus research"

DOI: 10.1016/j.virusres.2020.198000

Abstract: Lassa fever (LF) is a viral hemorrhagic illness endemic in West Africa. Annually, about 300,000 - 500,000 people are being infected, with about 5,000 deaths. Symptoms of LF include high grade fever, headache, malaise, abdominal… read more here.

Keywords: outcome; fever; prevalence; ebonyi state ... See more keywords
Photo by glenncarstenspeters from unsplash

Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever

Sign Up to like & get
recommendations!
Published in 2018 at "Scientific Reports"

DOI: 10.1038/s41598-018-24246-w

Abstract: Lassa fever, a hemorrhagic fever caused by Lassa virus (LASV), is endemic in West Africa. It is difficult to distinguish febrile illnesses that are common in West Africa from Lassa fever based solely on a… read more here.

Keywords: field; fever; recombinant antigen; lassa fever ... See more keywords
Photo from wikipedia

965. Applying Clinical Prediction Tools to Patients with Lassa Fever

Sign Up to like & get
recommendations!
Published in 2018 at "Open Forum Infectious Diseases"

DOI: 10.1093/ofid/ofy209.081

Abstract: Abstract Background Clinical prediction tools such as the Quick Sequential Organ Failure Assessment (qSOFA) and the Modified Early Warning Score (MEWS) have been used to predict mortality from sepsis in high-income countries, but their application… read more here.

Keywords: clinical prediction; prediction tools; patients lassa; lassa fever ... See more keywords
Photo by nampoh from unsplash

Safety and Pharmacokinetics of LHF-535, a Potential Treatment for Lassa Fever, in Healthy Adults

Sign Up to like & get
recommendations!
Published in 2022 at "Antimicrobial Agents and Chemotherapy"

DOI: 10.1128/aac.00951-22

Abstract: LHF-535 is a small-molecule antiviral currently under development as a therapeutic option to treat Lassa fever and other viral hemorrhagic fevers of arenavirus origin. The human safety and pharmacokinetics of LHF-535 were evaluated in two… read more here.

Keywords: safety pharmacokinetics; pharmacokinetics lhf; lhf 535; lassa fever ... See more keywords
Photo by aaronburden from unsplash

Prospective observational study on the pharmacokinetic properties of the Irrua ribavirin regimen used in routine clinical practice in patients with Lassa fever in Nigeria

Sign Up to like & get
recommendations!
Published in 2020 at "BMJ Open"

DOI: 10.1136/bmjopen-2020-036936

Abstract: Introduction Lassa fever (LF) is a severe and often fatal systemic disease in humans and affects a large number of countries in West Africa. Treatment options are limited to supportive care and the broad-spectrum antiviral… read more here.

Keywords: prospective observational; properties irrua; study; irrua ribavirin ... See more keywords
Photo from wikipedia

Re-emerging Lassa fever outbreaks in Nigeria: Re-enforcing “One Health” community surveillance and emergency response practice

Sign Up to like & get
recommendations!
Published in 2018 at "Infectious Diseases of Poverty"

DOI: 10.1186/s40249-018-0421-8

Abstract: We evaluated the impact of man-made conflict events and climate change impact in guiding evidence-based community “One Health” epidemiology and emergency response practice against re-/emerging epidemics. Increasing evidence of emerging and re-emerging zoonotic diseases including… read more here.

Keywords: response; fever; community; health ... See more keywords
Photo by markusspiske from unsplash

The West Africa Lassa fever Consortium pre-positioned protocol for a Phase II/III adaptive, randomised, controlled, platform trial to evaluate multiple Lassa fever therapeutics

Sign Up to like & get
recommendations!
Published in 2023 at "Wellcome Open Research"

DOI: 10.12688/wellcomeopenres.19041.1

Abstract: Background: This is a standardized, pre-positioned protocol for the coordinated evaluation of Lassa fever therapeutics. The protocol is the product of discussions that took place in 2021 and 2022 among international investigators from a wide… read more here.

Keywords: positioned protocol; pre positioned; fever; fever therapeutics ... See more keywords